Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

Clinical trial NCT04453813 · RECRUITING

Trial details

NCT number: NCT04453813
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma Chemotherapy Radiotherapy PD-1 Treatment

Start date: 2020-07-03
Primary completion: 2025-07-01
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.